StockData
Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc. (ALDX) stock

ALDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.69+0.02 (+3.63%)

Close on Nov 17, 2026Market cap $41.86MP/E –Yield –

Aldeyra Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Aldeyra Therapeutics's price to book ratio was 1.0× on Nov 11, 2026, against 6.7× a year earlier. Over the last 5 years it ranged from 0.6× to 7.4×, with a median of 2.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.0×−5.3
2025Dec 31, 20256.3×+2.8
2024Dec 31, 20243.5×+1.8
2023Dec 29, 20231.7×−0.8
2022Dec 30, 20222.5×+1.8
2021Dec 31, 20210.7×−3.1
2020Dec 31, 20203.8×+0.7
2019Dec 31, 20193.1×−3.0
2018Dec 31, 20186.1×+3.3
2017Dec 29, 20172.8×+0.2
2016Dec 30, 20162.6×+0.3
2015Dec 31, 20152.3×−2.6
2014Dec 31, 20144.9×–

More Aldeyra Therapeutics figures

See a number that looks wrong?